Ansun Biopharma
Karen Liu is a Director at Ansun Biopharma and a Board Member at Oncoimmune Inc. Karen has also served as a Partner at Kaiwu Capital and as COO/ acting CFO /SVP at 3721.com (Inter China Network Software). Prior to their current positions, they were an Associate / Project manager at McKinsey & Company.
Liu has over 20 years of experience in the biotech and pharmaceutical industries. Karen has expertise in strategy, operations, business development, and finance. Karen has a proven track record of success in building and leading high-performing teams.
Liu earned their MBA from Harvard Business School and their BA from Yale University.
Karen Liu has a Ph.D from Harvard University, an MMS from Harvard Medical School, a BS from Cornell University, and an EMBA from the CK Graduate School of Business (CKGSB).
This person is not in the org chart
This person is not in any offices
Ansun Biopharma
Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics.